Effect of methylphenidate in patients with cancer-related fatigue: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Gong, Shun ^a   Sheng, Ping ^a   Jin, Hai ^a   He, Hua ^a   Qi, Enbo ^a   Chen, Wen ^a   Dong, Yan ^a   Hou, Lijun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ANOREXIA; ANXIETY DISORDER; ARTICLE; CANCER FATIGUE; COGNITION; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; VERTIGO;

COGNITION; DEPRESSION; FATIGUE; HUMANS; METHYLPHENIDATE; NEOPLASMS;

EID: 84897087617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084391     Document Type: Article

References (43)

1. Minton O, Berger A, Barsevick A, Cramp F, Goedendorp M, et al. (2013) Cancer-related fatigue and its impact on functioning. Cancer 11: 2124-2130.
2. Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, et al. (2007) Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 5: 1054-1078.
3. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J (2004) Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32: 40-50.
4. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, et al. (2000) NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) 14: 151-161.
5. Hwang SS, Chang VT, Rue M, Kasimis B (2003) Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage 26: 604-614.
6. Barnes EA, Bruera E (2002) Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 12: 424-428.
7. Cramp F, Byron-Daniel J (2012) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 14: 11.
8. Dewey A (2010) Psychosocial interventions for reducing fatigue during cancer treatment in adults. Int J Evid Based Healthc 8: 106-107.
9. Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L (2010) Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 10: 11.
10. Jensen PS (2009) Review: methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms. Evid Based Ment Health 12: 18.
11. Simmler LD, Wandeler R, Liechti ME (2013) Bupropion, methylphenidate, and 3, 4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence. BMC Res Notes 6: 220.
12. Wiley MD, Poveromo LB, Antapasis J (2009) Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate. Neuropsychopharmacology 34: 1339-1350.
13. Candy M, Jones L, Williams R, Tookman A, King M (2008) Psychostimulants for depression. Cochrane Database Syst Rev 16: 2.
14. Cella D, Davis K, Breitbart W, Curt G (2001) Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19: 3385-3391.
15. Jacobsen PB, Thors CL (2003) Fatigue in the radiation therapy patient: Current management and investigations. Semin Radiat Oncol 13: 372-380.
16. Bruera E, Miller MJ, MacMillan K (1992) Neuropsychological effect of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48: 163-166.
17. Bruera E, Fainsinger R (1992) The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain50: 75-77.
18. Yennurajalingam S, Bruera E (2007) Palliative Management of Fatigue at the Close of Life: "It Feels Like My Body Is Just Worn Out". JAMA297: 295-304.
19. Bruera E, Driver L, Barnes EA (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer. J ClinOncol 21: 4439-4443.
20. Cella D, Peterman A, Passik S (1998) Progress toward guidelines for the management of fatigue. Oncology (Huntington) 12: 369-377.
21. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P (2010) Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev 7: 7.
22. Schwartz AL, Thompson JA, Masood N (2002) Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 29: 85-90.
23. Johnson RL, Block I, Gold MA, Markwell S, Zupancic M (2010) Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psycho-Oncology 19: 955-958.
24. Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, et al. (2012) A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol107: 165-174.
25. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 100: 1155-1166.
26. Minton O, Richardson A, Sharpe M, Hotopf M, Stone PC (2011) Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage 41: 761-767.
27. Fleishman S, Lower E, Zeldis J (2005) A phase II, randomized, placebo controlled trial of the safety and efficacy of dexmethylphenidate (d-MPH) as a treatment for fatigue and "chemobrain" in adult cancer patients. Breast Cancer Res Treat 94: 214.
28. Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, et al. (2007) A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCL in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69: 1496-1501.
29. Bruera E, Valero V, Driver L, Shen L, Willey J, et al. (2006) Patient controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24: 2073-2078.
30. Cueva JF, Calvo M, Anido U, León L, Gallardo E, et al. (2012) Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study. Invest New Drugs 30: 688-694.
31. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, et al. (2009) Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage 38: 650-662.
32. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, et al. (2010) Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial. J Clin Oncol 28: 3673-3679.
33. Roth AJ, Nelson C, Rosenfeld B, Scher H, Slovin S, et al. (2010) Methylphenidate for Fatigue in Ambulatory Men with Prostate Cancer. Cancer 116: 5102-5110.
34. Yennurajalingam S, Palmer JL, Chacko R, Bruera E (2011) Factors associated with response to methylphenidate in advanced cancer patients. Oncologist 16: 246-53.
35. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
36. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12.
37. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemiarelated symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13: 63-74.
38. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, et al. (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85: 1186-1196.
39. Higgins JPT, Green S, Collaboration C (2008) Cochrane handbook for systematic reviews of interventions: Wiley Online Library.
40. Addington AM, Gallo JJ, Ford DE, Eaton WW (2001) Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981-1994. Psychol Med 21: 1037-1044.
41. Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, et al. (2008) Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol 26: 3886-3895.
42. Godfrey J (2009) Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol 23: 194-205.
43. Conklin HM, Lawford J, Jasper BW, Morris EB, Howard SC, et al. (2009) Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. Pediatrics 124: 226-233.